3337-59-5

Basic information

• Product Name: METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE
• Synonyms: Methyl 3,5-Dichloro-4-Hydroxylbenzoate;RARECHEM AL BF 0933;3,5-DICHLORO-4-HYDROXYBENZOIC ACID METHYL ESTER;4-HYDROXY-3,5-DICHLOROBENZOIC ACID METHYL ESTER;AURORA 17218;METHYL-4-HYDROXY-3 5-DICHLOROBENZOATE;METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE;LABOTEST-BB LT00455579
• CAS NO: 3337-59-5
• Molecular Formula: C₈H₆Cl₂O₃
• Molecular Weight: 221.04
• EINECS: 222-074-5
• Product Categories: Chlorine Compounds;Phenols;Aromatic Esters;Phenylacetic acid;Acids & Esters
• Mol File: 3337-59-5.mol

Chemical Properties

• Melting Point: 122-125°C
• Boiling Point: 340.99°C (rough estimate)
• Flash Point: 136.9 °C
• Appearance: /
• Density: 1.4760 (rough estimate)
• Vapor Pressure: 0.000544mmHg at 25°C
• Refractive Index: 1.4800 (estimate)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 5.43±0.23(Predicted)
• CAS DataBase Reference: METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE(3337-59-5)
• EPA Substance Registry System: METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE(3337-59-5)

Safety Data

• Hazardous Substances Data: 3337-59-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE is used as an intermediate in the synthesis of various pharmaceutical compounds due to its unique chemical properties.
Used in Personal Care Products:
METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE is used as a preservative and antiseptic in skincare products and topical ointments, providing antimicrobial protection and extending the shelf life of these products.
Used in Industrial Applications:
METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE is used in the manufacturing of industrial products, such as pesticides, due to its effective antimicrobial properties.
Overall, METHYL 3,5-DICHLORO-4-HYDROXYBENZOATE is a valuable chemical with a wide range of applications across different industries, making it an essential component in various formulations and processes.

InChI:InChI=1/C8H6Cl2O3/c1-13-8(12)4-2-5(9)7(11)6(10)3-4/h2-3,11H,1H3

Upstream product

• 67-56-1 methanol 
• 3336-41-2 3,5-dichloro-4-hydroxybenzoic acid 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 67341-33-7 2,6-dichloro-4-methylanisole 
• 37908-97-7 3,5-dichloro-4-methoxybenzoic acid 
• 2432-12-4 2,6-dichloro-4-methylophenol 

Downstream Products

• 98557-37-0 1,2,3,3,5,5,6-heptachloro-4-oxo-cyclohexanecarboxylic acid methyl ester 
• 22002-17-1 3,5-dichloro-4-hydroxybenzyl alcohol 
• 2314-36-5 3,5-dichloro-4-hydroxybenzaldehyde 
• 212067-18-0 (R,S)-N-acetyl-α-(3,5-dichloro-4-hydroxyphenyl)glycine 
• 64879-84-1 1,3-bis-(4-carbomethoxy-2,6-dichlorophenoxymethyl)-2,4,5,6-tetrabromobenzene 
• 852947-85-4 3,5-dichloro-4-(4-methoxy-phenoxy)-benzoic acid methyl ester 
• 1272526-82-5 4-(3,5-dichloro-4-(cyclopentyloxy)benzamido)benzoic acid 
• 1272528-06-9 methyl 4-(4-(benzyloxy)-3,5-dichlorobenzamido)benzoate 
• 848297-61-0 methyl 4-(3,5-dichloro-4-hydroxybenzamido)benzoate 
• 1272528-30-9 methyl 4-(4-(tert-butoxy)-3,5-dichlorobenzamido)benzoate 
• 1272527-00-0 4-(3,5-dichloro-4-ethoxybenzamido)-2-methylbenzoic acid 
• 41490-08-8 3,5-dichloro-4-ethoxybenzoic acid 
• 41490-21-5 3,5-dichloro-4-ethoxy-benzoyl chloride 
• 41490-13-5 4-(benzyloxy)-3,5-dichlorobenzoicacid 

Relevant articles and documents

CLASS OF BIFUNCTIONAL COMPOUNDS WITH QUATERNARY AMMONIUM SALT STRUCTURE

The invention provides a class of compounds represented by formula (I), having bifunctional active quaternary ammonium salt structure of a β2-adrenoreceptor agonist and an M receptor antagonist, a pharmaceutically acceptable salt, solvate, and optical isomer thereof. A pharmaceutical composition comprising such a compound with quaternary ammonium salt structure, a method for preparing such a compound with quaternary ammonium salt structure and an intermediate thereof, and uses thereof in treating pulmonary disorders are also provided. The compounds of the invention have high selectivity to the M receptor subtype, and have less adverse reaction and lower toxic and side effects in the treatment of pulmonary diseases such as COPD and asthma.

ORGANIC COMPOUNDS

Novel benzofuran derivatives are disclosed. The derivatives have S1P1 receptor activity and/or disease modifying activity and find use in the treatment of conditions or diseases associated with the immune, vascular and nervous systems in animals and/or humans

Induction of apoptosis in cancer cells

The present invention provides compounds that are inducers or inhibitors of apoptosis or apoptosis preceded by cell-cycle arrest. In addition, the present invention provides pharmaceutical compositions and methods for treating mammals with leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells.

Benzisoxazole-derived antidiabetic compounds

The instant invention is concerned with acetylphenols which are useful as antiobesity and antidiabetic compounds. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering or modulating triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for increasing gut motility or for treating atherosclerosis are also disclosed.